| Jan 30 2024 |
Blue Diamond “Smokehouse” Almonds Challenged |
Keller and Heckman LLP |
| Jan 30 2024 |
China’s Supreme People’s Court Upholds 79 Million RMB Win for Château Lafite Rothschild in Wine Trademark Case |
Schwegman, Lundberg & Woessner, P.A. |
| Jan 29 2024 |
Gold Dome Report – Legislative Day 10 (2024) |
Nelson Mullins |
| Jan 29 2024 |
2024 Top-of-Mind Issues for Life Sciences Companies |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 26 2024 |
FDA Takes First Step Toward International Regulation of Gene Therapies to Treat Rare Diseases |
Greenberg Traurig, LLP |
| Jan 25 2024 |
FDA Lists Regulations Under Development and Updates Priority Guidance Topics for Foods Program |
Keller and Heckman LLP |
| Jan 25 2024 |
An Overview of the US Food and Drug Administration's Legislative Goals (Part I) |
K&L Gates LLP |
| Jan 25 2024 |
A New Era For New Jersey’s Liquor Law: Comprehensive Reforms Enacted |
Norris McLaughlin P.A. |
| Jan 24 2024 |
CY 2024 OPPS Final Rule Summary for RI Year-End Review |
Polsinelli PC |
| Jan 24 2024 |
“No Preservatives” Claim Challenged |
Keller and Heckman LLP |
| Jan 24 2024 |
High Expectations: New Jersey’s Rocky Road to Cannabis Consumption Lounges |
Norris McLaughlin P.A. |
| Jan 23 2024 |
Select Highlights from CY 24 Medicare Physician Fee Schedule Final Rule |
Polsinelli PC |
| Jan 23 2024 |
Trending in Telehealth: January 4 – 15, 2024 |
McDermott Will & Schulte LLP |
| Jan 23 2024 |
Fiji Water Maker Sued Over Microplastics |
Keller and Heckman LLP |
| Jan 23 2024 |
Florida PBM Law Limits Mail-Order Prescription Drug Programs, Requires State Filings by Employer Plans |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 22 2024 |
Gold Dome Report – Legislative Day 6 (2024) |
Nelson Mullins |
| Jan 22 2024 |
Federal Judge Rejects Pharma Manufacturers’ Challenge to Negative OIG Advisory Opinion |
Mintz |
| Jan 22 2024 |
Tips for Alcohol Suppliers Utilizing Social Media |
McDermott Will & Schulte LLP |
| Jan 21 2024 |
FDA Issues Final Rule and Guidance on Direct-To-Consumer Prescription Drug Advertisements |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 19 2024 |
Iowa Employers Must Ensure Strict Adherence to State’s Drug Testing Law |
Jackson Lewis P.C. |
| Jan 19 2024 |
This Week in 340B: January 9 – 16, 2024 |
McDermott Will & Schulte LLP |
| Jan 19 2024 |
Sponsored Genetic Testing Programs: Compliance Considerations Following DOJ False Claims Act Settlement |
Epstein Becker & Green, P.C. |
| Jan 19 2024 |
McDermottPlus Check-Up: January 19, 2024 |
McDermott Will & Schulte LLP |
| Jan 18 2024 |
Federal Circuit Affirms Skinny Label Carve Outs |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 18 2024 |
Shazam! Captain Cannabis Registration Defeated by Prior Analogous Trademark Use |
McDermott Will & Schulte LLP |
| Jan 18 2024 |
PTO Continues to Wave Wands in Assessing Enablement |
McDermott Will & Schulte LLP |
| Jan 18 2024 |
Ordinary Meaning: “Identifying” Doesn’t Mean Detecting; It Means Identifying |
McDermott Will & Schulte LLP |
| Jan 18 2024 |
China Solicits Comments on Food-Contact Coatings Standard |
Keller and Heckman LLP |
| Jan 18 2024 |
Quaker Oats Expands Recall to Cap’n Crunch Products |
Keller and Heckman LLP |
| Jan 17 2024 |
HSE Recommends Adding DIHxP to UK REACH Authorization List |
Bergeson & Campbell, P.C. |
| Jan 17 2024 |
California's Proposition 65: A Regulatory Conundrum |
Keller and Heckman LLP |
| Jan 17 2024 |
December 2023 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Jan 17 2024 |
FDA Approves Florida Importing Drugs from Canada |
Greenberg Traurig, LLP |
| Jan 17 2024 |
FDA Recommends that the DEA Reschedule Marijuana |
Keller and Heckman LLP |
| Jan 16 2024 |
Law Library of Congress Publishes Report on Selected Issues in Biotechnology Regulation |
Bergeson & Campbell, P.C. |
